Schedule 13G ownership disclosure

BIOAFFINITY TECHNOLOGIES INC

Common Stock, $0.007 par value · CUSIP: 09076W307

Event date: 2025-09-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIGGER CAPITAL FUND L P

    Shares: 58,682.00 · Class: 2.89%

  • Bigger Capital Fund GP, LLC

    Shares: 58,682.00 · Class: 2.89%

  • District 2 Capital Fund LP

    Shares: 58,682.00 · Class: 2.89%

  • District 2 Capital LP

    Shares: 58,682.00 · Class: 2.89%

  • District 2 GP LLC

    Shares: 58,682.00 · Class: 2.89%

  • District 2 Holdings LLC

    Shares: 58,682.00 · Class: 2.89%

  • Bigger Michael

    Shares: 117,364.00 · Class: 5.79%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-002656
Form type
SCHEDULE 13G
Filer
BIGGER CAPITAL FUND L P
CIK
CIK 1288478
Filed
Oct 01, 2025
Reporting period
Sep 29, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub